New Living With AxSpA, PsA and RA syndicated patient reports launched
We are excited to announce the launch of our latest syndicated patient reports focused on Axial Spondyloarthritis (AxSpA), Psoriatic Arthritis (PsA), and Rheumatoid Arthritis (RA) covering EU4/UK and Japan. These reports provide a foundational view of the patient experience, highlighting critical unmet needs, treatment expectations, and the impact of these diseases on daily life.
Based on quantitative and qualitative interviews with patients, these reports have helped our clients develop a better understanding of patient unmet needs, patients’ views on treatments and how they seek and use disease information and support. Clients can use insights to better inform clinical trial planning, improve patient engagement strategies and provide improved support for patients. Explore these reports to gain valuable perspectives on enhancing the quality of life for those managing AxSpA, PsA, and RA.
For more information, please contact us today.
Jump to a slide with the slide dots.
ASH® 2025 roundtable: Turning hematology innovation into real world progress
Insights from ASH® 2025 on hematology innovation, CAR-T, bispecifics, diagnostics, and how connected strategy supports real-world adoption.
Read moreFrom High Hopes to Hesitation: Tracking the Shifting Barriers to Alzheimer’s DMT adoption
Why Alzheimer’s DMT uptake remains low: Explore key barriers, diagnostic gaps, and market insights from 783 physicians worldwide.
Read moreLaunch command centers predict pharma launch risk with agentic AI
Agentic AI–powered launch command centers predict pharma launch risks and enable faster, smarter decisions for successful product launches.
Read more